ZNF148
Zinc finger protein 148
Also known as: BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148, ZN148_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UQR1
- Gene
- ZNF148
- Ensembl
- ENSG00000163848
- Chromosome
- 3
- Canonical length
- 794 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
The protein encoded by this gene is a member of the Kruppel family of zinc finger DNA binding proteins. The encoded protein activates transcription of the T-cell receptor and intestinal alkaline phosphatase genes but represses transcription of the ornithine decarboxylase, vimentin, gastrin, stomelysin, and enolase genes. Increased expression of this gene results in decreased patient survival rates from colorectal cancer, while mutations in this gene have been associated with global developmental delay, hypoplastic corpus callosum, and dysmorphic facies. [provided by RefSeq, Feb 2017]
Canonical amino-acid sequenceUniProt
794 residues, UniProt reviewed canonical sequence.
>Q9UQR1|ZNF148
1 MNIDDKLEGL FLKCGGIDEM QSSRTMVVMG GVSGQSTVSG ELQDSVLQDR SMPHQEILAA
61 DEVLQESEMR QQDMISHDEL MVHEETVKND EEQMETHERL PQGLQYALNV PISVKQEITF
121 TDVSEQLMRD KKQIREPVDL QKKKKRKQRS PAKILTINED GSLGLKTPKS HVCEHCNAAF
181 RTNYHLQRHV FIHTGEKPFQ CSQCDMRFIQ KYLLQRHEKI HTGEKPFRCD ECGMRFIQKY
241 HMERHKRTHS GEKPYQCEYC LQYFSRTDRV LKHKRMCHEN HDKKLNRCAI KGGLLTSEED
301 SGFSTSPKDN SLPKKKRQKT EKKSSGMDKE SALDKSDLKK DKNDYLPLYS SSTKVKDEYM
361 VAEYAVEMPH SSVGGSHLED ASGEIHPPKL VLKKINSKRS LKQPLEQNQT ISPLSTYEES
421 KVSKYAFELV DKQALLDSEG NADIDQVDNL QEGPSKPVHS STNYDDAMQF LKKKRYLQAA
481 SNNSREYALN VGTIASQPSV TQAAVASVID ESTTASILES QALNVEIKSN HDKNVIPDEV
541 LQTLLDHYSH KANGQHEISF SVADTEVTSS ISINSSEVPE VTPSENVGSS SQASSSDKAN
601 MLQEYSKFLQ QALDRTSQND AYLNSPSLNF VTDNQTLPNQ PAFSSIDKQV YATMPINSFR
661 SGMNSPLRTT PDKSHFGLIV GDSQHSFPFS GDETNHASAT STQDFLDQVT SQKKAEAQPV
721 HQAYQMSSFE QPFRAPYHGS RAGIATQFST ANGQVNLRGP GTSAEFSEFP LVNVNDNRAG
781 MTSSPDATTG QTFGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF148 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 28 nTPM
- thymus: 16 nTPM
- parathyroid gland: 15 nTPM
- heart muscle: 14 nTPM
- ovary: 14 nTPM
- tonsil: 13 nTPM
Single-cell type
- neutrophils: 648 nCPM
- microglia: 379 nCPM
- neutrophil progenitors: 371 nCPM
- myonuclei: 355 nCPM
- gonadotrophs: 315 nCPM
- podocytes: 293 nCPM
Immune cell
- neutrophil: 50 nTPM
- NK-cell: 32 nTPM
- eosinophil: 31 nTPM
- naive CD4 T-cell: 27 nTPM
- memory B-cell: 24 nTPM
- non-classical monocyte: 23 nTPM
Brain region
- hypothalamus: 72 nTPM
- cerebellum: 66 nTPM
- cerebral cortex: 65 nTPM
- thalamus: 60 nTPM
- basal ganglia: 59 nTPM
- white matter: 56 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZNF148.
Disease | AllUniProt
Conditions ZNF148 is implicated in, by any mechanism.
- Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies (GDACCF) MIM:617260
Disease | GeneticClinVar
27 pathogenic / likely-pathogenic of 166 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.1
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.52
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular defense response
- gamete generation
- negative regulation of DNA-templated transcription
- negative regulation of gene expression
- negative regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- substantia nigra development
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF148 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF148 as an antibody target. Whether an autoantibody or antibody against ZNF148 could matter depends on whether native ZNF148 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF148 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF148 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...